TY - JOUR
T1 - Cerebral palsy and the placenta
T2 - A review of the maternal-placental-fetal origins of cerebral palsy.
AU - Chin, Eric M.
AU - Gorny, Nicole
AU - Logan, Maya
AU - Hoon, Alexander H.
N1 - Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/6
Y1 - 2022/6
N2 - Accumulating evidence from clinical and neuropathological study has identified a number of seemingly disparate associations carrying a predisposition for cerebral palsy (CP). We narratively reviewed clinical studies reporting associations between prenatal and perinatal environmental factors and the risk of developing CP. As expected, some processes with direct central nervous system involvement (e.g. perinatal hypoxic-ischemic encephalopathy or infectious encephalomalacia) carry >10% absolute risk of CP. Other acute perinatal processes including placental abruption, uterine rupture, and neonatal sepsis are also associated with increased risk of CP but carry <3% absolute risk of CP. Indirect markers of chronic placental insufficiency such as fetal and placental growth patterns are associated with increased risk of CP, and risk of CP in infants with growth abnormalities born extremely preterm exceeds 10%. We synthesize these findings within a framework of risk accumulating across several defined pre- and perinatal developmental windows. Causal links remain incompletely understood, but genetic background, the intrauterine environment, general fetal health, and fetal neurologic health all appear to contribute.
AB - Accumulating evidence from clinical and neuropathological study has identified a number of seemingly disparate associations carrying a predisposition for cerebral palsy (CP). We narratively reviewed clinical studies reporting associations between prenatal and perinatal environmental factors and the risk of developing CP. As expected, some processes with direct central nervous system involvement (e.g. perinatal hypoxic-ischemic encephalopathy or infectious encephalomalacia) carry >10% absolute risk of CP. Other acute perinatal processes including placental abruption, uterine rupture, and neonatal sepsis are also associated with increased risk of CP but carry <3% absolute risk of CP. Indirect markers of chronic placental insufficiency such as fetal and placental growth patterns are associated with increased risk of CP, and risk of CP in infants with growth abnormalities born extremely preterm exceeds 10%. We synthesize these findings within a framework of risk accumulating across several defined pre- and perinatal developmental windows. Causal links remain incompletely understood, but genetic background, the intrauterine environment, general fetal health, and fetal neurologic health all appear to contribute.
KW - Cerebral palsy
KW - Intrauterine environment
KW - Neurodevelopmental disabilities
KW - Placenta
UR - http://www.scopus.com/inward/record.url?scp=85125270324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125270324&partnerID=8YFLogxK
U2 - 10.1016/j.expneurol.2022.114021
DO - 10.1016/j.expneurol.2022.114021
M3 - Article
C2 - 35196502
AN - SCOPUS:85125270324
SN - 0014-4886
VL - 352
JO - Experimental Neurology
JF - Experimental Neurology
M1 - 114021
ER -